1. Home
  2. NLSP vs BDRX Comparison

NLSP vs BDRX Comparison

Compare NLSP & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • BDRX
  • Stock Information
  • Founded
  • NLSP 2015
  • BDRX 2000
  • Country
  • NLSP Switzerland
  • BDRX United Kingdom
  • Employees
  • NLSP N/A
  • BDRX N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NLSP Health Care
  • BDRX Health Care
  • Exchange
  • NLSP Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • NLSP 8.2M
  • BDRX 9.6M
  • IPO Year
  • NLSP 2021
  • BDRX N/A
  • Fundamental
  • Price
  • NLSP $0.19
  • BDRX $0.80
  • Analyst Decision
  • NLSP Hold
  • BDRX Strong Buy
  • Analyst Count
  • NLSP 1
  • BDRX 1
  • Target Price
  • NLSP N/A
  • BDRX $8.00
  • AVG Volume (30 Days)
  • NLSP 11.0M
  • BDRX 4.2M
  • Earning Date
  • NLSP 07-30-2024
  • BDRX 04-19-2024
  • Dividend Yield
  • NLSP N/A
  • BDRX N/A
  • EPS Growth
  • NLSP N/A
  • BDRX N/A
  • EPS
  • NLSP N/A
  • BDRX N/A
  • Revenue
  • NLSP N/A
  • BDRX $482,278.00
  • Revenue This Year
  • NLSP N/A
  • BDRX N/A
  • Revenue Next Year
  • NLSP N/A
  • BDRX N/A
  • P/E Ratio
  • NLSP N/A
  • BDRX N/A
  • Revenue Growth
  • NLSP N/A
  • BDRX N/A
  • 52 Week Low
  • NLSP $0.11
  • BDRX $0.67
  • 52 Week High
  • NLSP $1.21
  • BDRX $9.64
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 49.01
  • BDRX 42.17
  • Support Level
  • NLSP $0.19
  • BDRX $0.91
  • Resistance Level
  • NLSP $0.24
  • BDRX $1.20
  • Average True Range (ATR)
  • NLSP 0.03
  • BDRX 0.14
  • MACD
  • NLSP -0.00
  • BDRX 0.00
  • Stochastic Oscillator
  • NLSP 15.85
  • BDRX 9.48

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: